NCT06883032

Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions

Validation of the QuickSee Plus Device

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 92 (actual)
• Sponsor: PlenOptika, Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

At the New England College of Optometry in Boston, MA, subjects ages 18-65 who have received or are receiving treatment for refractive error who choose to enroll in the study will be evaluated using subjective refraction and automated refraction, by way of the QuickSee Plus refractor. Subjects will then be randomized into one of two treatment plans: receive glasses from automated refraction first then subjective refraction second, and vice versa. After one week of wearing the first pair of glasses, patient preferences are assessed, and glasses are switched. After a week of wearing the second pair of glasses from the alternate measurement method, patient preferences are again assessed. Patients may then decide which pair patient like best. This is a triple blind, case-crossover clinical trial.

Conditions

• Refractive Errors

Interventions

Type	Name	Description
OTHER	AR Eyeglasses first, SR Eyeglasses second	First Eyeglasses based on Automated Refraction, Second Eyeglasses based on Subjective Refraction
OTHER	SR Eyeglasses first, AR Eyeglasses second	First Eyeglasses based on Subjective Refraction, Second Eyeglasses based on Automated Refraction

Timeline

• Start date: 2025-02-16
• Primary completion: 2025-02-28
• Completion: 2025-02-28
• First posted: 2025-03-19
• Last updated: 2025-08-01

Locations

1 site across 1 country: United States